The role of GABAergic system in neurodevelopmental disorders: a focus on autism and epilepsy

Insights

Autism spectrum disorder (ASD) and epilepsy share common neurodevelopmental origins, often linked to GABAergic circuit dysfunction. This imbalance in neuronal inhibition may be a key factor in both childhood neurological disorders.

Area of Science:

  • Neuroscience
  • Developmental disorders
  • Neurology

Background:

  • Autism spectrum disorder (ASD) and epilepsy are prevalent childhood neurological conditions.
  • These disorders frequently co-occur, suggesting shared underlying causes.
  • Genetic, neuroimaging, and neuropathological studies support common neurodevelopmental bases.

Purpose of the Study:

  • To review evidence supporting GABAergic circuit dysfunction as a common pathogenetic mechanism for ASD and epilepsy.
  • To explore the link between neurodevelopmental defects in GABAergic circuitry and these disorders.

Main Methods:

  • Review of significant genetic, neuroimaging, and neuropathological studies.
  • Analysis of research on animal models and postmortem human samples.
  • Examination of studies investigating GABAergic neuron and circuit alterations.

Main Results:

  • Evidence indicates altered GABAergic neurons and circuits in both ASD and epilepsy.
  • Dysfunction of inhibitory GABAergic circuits is proposed as a cause for both conditions.
  • An excitation/inhibition imbalance due to GABAergic defects is a potential common mechanism.

Conclusions:

  • GABAergic circuit dysfunction is a significant shared neurodevelopmental basis for ASD and epilepsy.
  • This imbalance contributes to the pathogenesis of both disorders.
  • Further research into GABAergic mechanisms is warranted.

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...